QurAlis Expands its Industry-Leading Precision Medicine Approach in Splicing Targets Beyond Neurodegeneration Into Fragile X Syndrome (FXS)

Company initiates partnership and collaboration with UMass Chan Medical School to characterize relevant targets that enable ASO-mediated correction for FXS Fragile X syndrome is a rare, genetic neurological disease that is the leading inherited form of intellectual disability and a known…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.